Intellectual Property

  • February 03, 2026

    TikTok, Cellspin Duel On Effects Of Sale In Patent Challenge

    TikTok has told the U.S. Patent and Trademark Office that the sale of its majority stake in its U.S. operations to a new joint venture should eliminate a patent owner's argument that the app's alleged relationship with the Chinese Communist Party should tank its patent challenges.

  • February 03, 2026

    Feds, Samsung Urge Justices To Reject PTAB Prior Art Case

    The federal government and Samsung have both urged the U.S. Supreme Court to reject a patent owner's challenge to the Federal Circuit's finding that the filing date of a patent dictates if it can be considered prior art.

  • February 03, 2026

    Tobacco Co. Says 'Time Bubble' Robbed It Of Fair TM Trial

    BBK Tobacco & Foods LLP is asking an Arizona federal court for a new trial on its trademark infringement claims against Central Coast Agriculture Inc., saying the court wrongly created a "time bubble" that excluded all evidence from May 2021 on.

  • February 03, 2026

    USPTO, With Squires' Signature, Seeks 'Board Of Peace' TMs

    The U.S. Patent and Trademark Office has filed a pair of applications for trademarks covering President Donald Trump's Board of Peace, with Director John Squires listed as the attorney pursuing the marks. 

  • February 03, 2026

    ATV Co. Accuses Rival Of Infringing Patents On Side-By-Sides

    Recreational vehicle manufacturer Polaris Inc. accused a rival of infringing its patents related to multi-occupant ATVs known as side-by-sides in two venues, filing a patent infringement suit in Minnesota federal court while also petitioning the U.S. International Trade Commission for an import ban on the products.

  • February 03, 2026

    Pharma Co. Stole Secrets For LSD Medical Trials, Suit Says

    A clinical trial services company is suing Definium Therapeutics Inc. in Delaware federal court, alleging that it stole trade secrets during Phase 2 trials of LSD treatments for psychiatric disorders, then passed those secrets on to a rival services company for Phase 3 trials.

  • February 03, 2026

    Fed. Circ. Backs Nearmap Win On 2 Out Of 3 PTAB Challenges

    The Federal Circuit on Tuesday stood by Nearmap's successful challenges at the Patent Trial and Appeal Board to a pair of patents covering a system for identifying attributes in a roof by using aerial imagery, but also refused to undo its unsuccessful challenge to another patent.

  • February 03, 2026

    4 Attys Sanctioned Over AI Hallucinations In Legal Brief

    A Kansas federal judge has issued sanctions against a group of lawyers representing a technology company in a patent dispute and has referred one attorney for disciplinary action over case citations hallucinated by ChatGPT appearing in a legal brief.

  • February 03, 2026

    Amway Looks To Sidestep Gut Drink Trademark Fight In NC

    Multi-level marketing giant Amway is seeking an early exit from a trademark infringement suit brought by a supplement maker in North Carolina, saying it has no ties to the Tar Heel state sufficient to be dragged into court there.

  • February 03, 2026

    Full Fed. Circ. Won't Rethink $162K Fee Award In Ramey Case

    The Federal Circuit will not reconsider its earlier ruling upholding a $162,000 fee award against a patent owner represented by attorney William Ramey III and his firm, Ramey LLP, after a district court found Ramey had brought a "weak" patent suit against television maker Vizio.

  • February 03, 2026

    1st Circ. Pushes For Settlement In Mass. 'Right-To-Repair' Suit

    The First Circuit suggested Tuesday that major automakers and the Massachusetts Attorney General's Office should work together to resolve a suit over compliance with a state law requiring open access to vehicle telematics systems.

  • February 02, 2026

    Businessman Fights Sanctions In $500M Miss America Feud

    Attorneys for a Florida businessman locked in a $500 million dispute over the ownership of the Miss America pageant urged a federal judge Monday not to sanction their client for filing allegedly false documents, arguing they withdrew the documents once they were notified of questions about their authenticity.

  • February 02, 2026

    Fed. Circ. Grapples With AI Patent Eligibility In Amazon Case

    A Federal Circuit panel on Monday expressed skepticism about Rensselaer Polytechnic Institute's argument that an artificial intelligence-related patent it sued Amazon over was wrongly invalidated as abstract, though the court seemed wary of issuing a ruling that could render all AI unpatentable.

  • February 02, 2026

    Judge Clears Apple Of Some Haptic Patent Claims

    A California federal judge has allowed Apple to escape some patent claims brought by a company that accused the tech giant of infringing the business's vibration technology patents, letting Apple escape literal infringement allegations related to its "monolithic products."

  • February 02, 2026

    Pandora Settles IP Suits By Robin Williams, Other Comedians

    Pandora Media has resolved yearslong copyright infringement litigation by Robin Williams' estate, Lewis Black and other comedians, who alleged the streaming service owes millions for wrongfully profiting off their performances and works without licensing agreements, following a settlement conference in California federal court Friday.

  • February 02, 2026

    'Star Trek'-Citing Judge Says Moderna Can't Ax $5B Vax IP Suit

    Moderna Inc. will have to face most of a rival mRNA vaccine developer's $5 billion patent suit over the company's COVID-19 vaccines at a trial in Delaware, a federal judge ruled on Monday, invoking "Star Trek" in a summary judgment order that left issues like patent invalidity up to the jury.

  • February 02, 2026

    Fed. Circ. Backs CIT's Objection To ITC Wholesale Redactions

    A Federal Circuit panel on Monday affirmed a U.S. Court of International Trade ruling finding the U.S. International Trade Commission was out of line in automatically making all questionnaire responses confidential, saying the CIT "struck the appropriate balance" between confidentiality and public access concerns.

  • February 02, 2026

    Modelo, Constellation Seek Permanent Ban On Fake Beers

    Constellation Brands, the exclusive licensee of Modelo's beer brands in the U.S., has asked a Texas federal judge for a permanent injunction against a beer distributor accused of importing and selling counterfeit beers that use labels that copy major Mexican beer brands.

  • February 02, 2026

    PTAB Sinks Samsung Challenge To Ouraring Patent

    The Patent Trial and Appeal Board has shot down Samsung Electronics Co. Ltd.'s challenge to an Ouraring Inc. smart ring patent amid an ongoing legal dispute that has spanned the board, federal district court and the U.S. International Trade Commission.

  • February 02, 2026

    Split Fed. Circ. Won't Revive Massager Design Patent Case

    A Maine federal judge properly found Armaid Co. Inc. didn't infringe Range of Motion Products LLC's design patent covering a personal massage device, a divided Federal Circuit held Monday.

  • February 02, 2026

    Wireless Charger Rivals Settle Patent Suit On Eve Of Trial

    An Israeli wireless power technology company has agreed to settle its suit alleging a Chinese electronics manufacturer infringed various power transmission patents, a move that came the day before trial was set to commence.

  • February 02, 2026

    Songwriter Says He Was Never Paid For Song In 'Smurfs' Film

    A musician has sued Paramount Pictures, claiming he was never compensated for a song he wrote that was recorded by singer Rihanna and was used in the "Smurfs" movie and that the studio tried to blame the singer when confronted.

  • February 02, 2026

    Tracy Anderson Workouts Are Copyrightable, 9th Circ. Told

    Celebrity fitness trainer Tracy Anderson urged the Ninth Circuit on Monday to reverse a ruling that invalidated copyrights to her "Tracy Anderson Method" workout routines, arguing that her routines are expressive protectable works distinct from yoga poses at issue in the Ninth Circuit's Bikram ruling.

  • February 02, 2026

    Nvidia Faces New Class Action Over AI YouTube Scraping

    Chipmaker and artificial intelligence company Nvidia has been hit with more claims of improperly scraping data from YouTube for training material for its AI model Cosmos.

  • February 02, 2026

    Judge Skeptical Of XAI's Claims In OpenAI Trade Secrets Suit

    A California federal judge has said she's inclined to grant OpenAI's motion to dismiss a trade secrets complaint from Elon Musk's xAI "in full," saying the plaintiffs have not provided enough facts to support claims that OpenAI poached employees and stole source code.

Expert Analysis

  • Beaming Up Lessons From William Shatner's Failed Patent Bid

    Author Photo

    In a tale that boldly goes where few celebrity inventors have gone before, William Shatner's unsuccessful attempt to patent a smartphone file organization system offers insights about potential pitfalls to avoid in patent applications, say attorneys at King & Spalding.

  • The Pros And Cons Of Levying Value-Based Fees On Patents

    Author Photo

    The potential for a recurring, value-based maintenance fee on patents, while offering some benefits, raises several complications, including that it would likely exceed the U.S. Patent and Trademark Office's statutory authority and reduce research and development activities in the U.S., says Sandip Patel at Marshall Gerstein.

  • Strategies To Get The Most Out Of A Mock Jury Exercise

    Author Photo

    A Florida federal jury’s recent $329 million verdict against Tesla over a fatal crash demonstrates how jurors’ perceptions of nuanced facts can make or break a case, and why attorneys must maximize the potential of their mock jury exercises to pinpoint the best trial strategy, says Jennifer Catero at Snell & Wilmer.

  • Series

    Writing Musicals Makes Me A Better Lawyer

    Author Photo

    My experiences with writing musicals and practicing law have shown that the building blocks for both endeavors are one and the same, because drama is necessary for the law to exist, says Addison O’Donnell at LOIS Law.

  • Between The Lines Of EPO's Adoption Of Color Drawings

    Author Photo

    The European Patent Office's decision to accept patent drawings in color starting in October may enhance clarity in technical disclosures and streamline the examination process, and could also enable new patent filing strategies for international applicants, say attorneys at Miller Canfield.

  • Series

    Adapting To Private Practice: From Va. AUSA To Mid-Law

    Author Photo

    Returning to the firm where I began my career after seven years as an assistant U.S. attorney in Virginia has been complex, nuanced and rewarding, and I’ve learned that the pursuit of justice remains the constant, even as the mindset and client change, says Kristin Johnson at Woods Rogers.

  • 2 Fed. Circ. Rulings Underscore Patent Prosecution Pitfalls

    Author Photo

    Two recent patent decisions from the Federal Circuit, overturning significant judgments, serve as reminders that claim modifications and cancellations may have substantive effects on the scope of other claims, and that arguments distinguishing prior art and characterizing claims may also limit claim scope, say attorneys at Morgan Lewis.

  • 7 Document Review Concepts New Attorneys Need To Know

    Author Photo

    For new associates joining firms this fall, stepping into the world of e-discovery can feel like learning a new language, but understanding a handful of fundamentals — from coding layouts to metadata — can help attorneys become fluent in document review, says Ann Motl at Bowman and Brooke.

  • Fed. Circ. Rulings Refine Patent Claim Construction Standards

    Author Photo

    Four Federal Circuit patent decisions this year clarify several crucial principles governing patent claim construction, including the importance of prosecution history, and the need for error-free, precise language from claims drafters, say attorneys at Taft.

  • Avoiding Unforced Evidentiary Errors At Trial

    Author Photo

    To avoid self-inflicted missteps at trial, lawyers must plan their evidentiary strategy as early as their claims and defenses, with an eye toward some of the more common pitfalls, says Nate Sabri at Perkins Coie.

  • How Value-Based Patent Fees May Shape IP Strategies

    Author Photo

    If the U.S. Patent and Trademark Office implements rumored plans to correlate patent fees with patent value, the financial and strategic consequences would largely depend on the specifics of how, when and how often patent values are assessed, say attorneys at Cleary.

  • Agentic AI Puts A New Twist On Attorney Ethics Obligations

    Author Photo

    As lawyers increasingly use autonomous artificial intelligence agents, disciplinary authorities must decide whether attorney responsibility for an AI-caused legal ethics violation is personal or supervisory, and firms must enact strong policies regarding agentic AI use and supervision, says Grace Wynn at HWG.

  • Using Reissue Applications To Strategically Improve Patents

    Author Photo

    Though reissue applications are an often-overlooked consideration in today's patent environment, they can offer powerful tools for correcting errors, strengthening patent protection, or adapting to evolving business and legal landscapes, says Curtis Powell at Wolf Greenfield.

  • Series

    Being A Professional Wrestler Makes Me A Better Lawyer

    Author Photo

    Pursuing my childhood dream of being a professional wrestler has taught me important legal career lessons about communication, adaptability, oral advocacy and professionalism, says Christopher Freiberg at Midwest Disability.

  • Patent Claim Lessons From Fed. Circ.'s Teva Decision

    Author Photo

    The Federal Circuit's recent decision in Janssen v. Teva is an important precedent for parties drafting patent claims or litigating obviousness where the prior art has potentially overlapping ranges for a claimed element, and may be particularly instructive to patent applicants in the pharmaceutical field, say attorneys at Cooley.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.